DTDian Wahyu Tanjung

Dian Wahyu Tanjung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dian Wahyu Tanjung has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Profile of Invasive Fungal Diseases (IFD) among Severely Critically Ill non-neutropenic patients in the HCU or ICU at a Single Referral Hospital in Indonesia

    by Siti Pratiekauri, Nina Mariana, Aninda Dinar Widiantari, Maria Lawrensia Tampubolon, Surya Oto Wijaya, Rosamarlina Rosamarlina, Dian Wahyu Tanjung, Farida Murtiani

    Invasive fungal diseases (IFD) are responsible for more than 1.5 million deaths globally annually. Candida spp. and Aspergillus spp. are the most frequent causes of healthcare-associated fungal infections, particularly in critically ill patients. This study aimed to describe severely critically ill patients with IFD caused by Candida spp. and Aspergillus spp. A cross-sectional study was conducted from July to December 2021 in the High Care Unit (HCU) and Intensive Care Unit (ICU) of Sulianti Saroso Hospital. We enrolled non-neutropenic patients with pneumonia or sepsis. Blood, lung exudate, and urine samples were collected from each patient for fungal testing. We performed mycological examination by culture and serology (galactomannan test used to detect Aspergillus antigen). Proven, probable, and possible are proposed as levels of IFD probability. Descriptive statistics were used to summarize the variables. Among 67 severely crititcally ill patients in the HCU and ICU who met the criteria. Blood samples were collected from 48 males and 19 females and then investigated. Most patients experienced pneumonia (87.0%), respiratory failure (76.1%), and sepsis (56.7%). Candida albicans was most commonly found in sputum (28.4%) and urine (25.4%), while Aspergillus fumigatus was found in sputum (3.0%). Candida parapsilosis and Candida duobushaeminlonii were found in the blood (4.5% and 1.5%, respectively), which is causing probable and possible IFDs. This study showed that invasive fungal disease was identified in non-neutropenic patients with severe to critical cases at HCU/ICU. The main cause of IFD is Candida albicans, while a small number of cases are caused by Aspergillus fumigatus, Aspergillus flavus, and Aspergillus niger. The fungi are commonly found in sputum and urine, whereas Candida duobushaemulonii and Candida parapsilosis were detected in blood cultures.

  • Open Access

    Biomarkers for predicting COVID-19 mortality: A study at Sulianti Saroso Infectious Disease Hospital, Indonesia

    by Siti Maemun, Aninda D. Widiantari, Farida Murtiani, Herlina Herlina, Dian W. Tanjungsari, Kunti Wijiarti, Tiara Z. Pratiwi, Faisal Matondang, Adria Rusli, Rivaldiansyah Rivaldiansyah, et al.

    The high transmissibility and mortality rates of the COVID-19 pandemic pose significant challenges. Patients can deteriorate rapidly, making it crucial to identify laboratory biomarkers for high-risk individuals. The aim of this study was to evaluate the predictive value of various laboratory parameters, including C-reactive protein (CRP), D-dimer, ferritin, neutrophil-to-lymphocyte ratio (NLR), prothrombin time (PT), and procalcitonin (PCT), in predicting COVID-19 mortality. A retrospective cohort study was conducted at Sulianti Saroso Infectious Disease Hospital, where COVID-19 patients were categorized into survivors and non-survivors. The Mann-Whitney test was used to assess group differences, while receiver operating characteristic (ROC) curve analysis was performed to evaluate the predictive performance of each biomarker, with Youden's index (J) determining optimal cut-off values. Kaplan-Meier analysis was used to compare median survival times, and Cox regression assessed hazard rates and the relationship between biomarkers and mortality. A total of 1,598 patients were analyzed, the majority of whom were admitted with oxygen saturation levels >95% and classified as having mild to moderate disease severity. Among them, 216 patients died, resulting in a mortality rate of 13.52%. Significant variations in mortality rates were observed along the survival functions for NLR, ferritin, D-dimer, CRP, and PCT (p<0.001). The survival curves for these biomarkers demonstrated distinct trends across tertiles over time. Among hematological markers, NLR was significantly associated with mortality (p<0.001), with a 1.5–2.2% increased risk per unit increase. Biochemical markers (complete blood count) proved to be more effective than hematological parameters (NLR, ferritin, PT, D-dimer, CRP, PCT) when evaluating individual prognostic performance. Bivariate analysis of CRP, D-dimer, ferritin, NLR, PT, and PCT between survivors and non-survivors showed significant differences. Notably, NLR and PCT were highly relevant for predicting disease prognosis and mortality, with sensitivity and specificity values exceeding 80%.


  • Open Access

    Quantitative Antibody Levels in Hospital Workers after Receiving three Doses of CoviD-19 vaccines

    by Pompini Agustina Sitompul, Nina Mariana, Ervan Budiman, Dian Wahyu Tanjung, Betha Ariesanty, Teguh Sarry Hartono, Jahiroh Jahiroh, Christine Ernita, Aninda Dinar, Anita Puspitasari, et al.

    Hospital workers were at high risk for SARS-CoV-2 infection and the first population with authorized access to the three doses of vaccination against SARS-CoV-2 antigen. The study was aimed to compare SARS-CoV-2 antibody levels among hospital workers receiving the three doses of Covid-19 vaccines with a history of Covid-19 infection versus those without a history of infection. A cross sectional study was conducted at the Sulianti Saroso Infectious Disease Hospital (SSIDH) in December 2021. The inclusion criteria were hospital workers in both subjects with and without previous Covid-19 infection and those who had received 3 doses of Covid-19 vaccines. Anti SARS-CoV-2 antibody levels measured by the Architect of SARS-CoV-2 IgG II Quant. There were 75 participants in the study, the median of anti SARS CoV-2 levels reported 8724.4 AU/mL (3396.8, 15773.2 AU/mL, Interquartile range). They were divided into 2 groups according to the status of prior Covid-19 infection, hospital workers with and without previous of Covid-19 infection. There was no significance difference in antibody less than 25.000 AU/mL between hospital worker with and without previous Covid-19 infection (p=1,000). Meanwhile, the median of antibody levels was seen in the interval between the 3rd dose of vaccine within 1 month; 2 to 3 months; 4 to 5 months before the antibody measurement (14576.5 AU/mL;12407.4 AU/mL; 5778.1 AU/mL, respectively). In this study, after three doses of Covid-19 vaccines, there was no significance difference in antibody levels of hospital worker with and without previous Covid-19 infection.